MindWalk Holdings Corp.
As of Oct 22, 2026, MindWalk Holdings is in Stage 1, the basing phase, now in week 2 (since Oct 15, 2026). It closed at $1.20, 56.8% below its 52-week high and below its 200-day average, which is falling.
MindWalk Holdings Corp. operates as a bio-native AI company. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is HYFT early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
HYFT among Biotechnology247th of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …247 | HYFT | Stage 1 · wk 2 | 39 | −13.7% |
MindWalk Holdings: quick answers
What stage is MindWalk Holdings in?
As of Oct 22, 2026, MindWalk Holdings (HYFT) is in Stage 1, the basing phase. It entered Stage 1 on Oct 15, 2026 and is in week 2. What the four stages mean
Is MindWalk Holdings in an uptrend?
Not yet. MindWalk Holdings is in Stage 1, a base that can come before an uptrend. It trades 16.6% below its 200-day average, which is falling.
How far is MindWalk Holdings from its 52-week high?
MindWalk Holdings closed at $1.20 on Oct 22, 2026, 56.8% below its 52-week high of $2.78. Its 52-week low is $1.02.
How has MindWalk Holdings performed over the past year?
As of Oct 22, 2026, MindWalk Holdings is down 21.1% over the past year and down 40.6% so far in 2026.
Which sector and industry is MindWalk Holdings in?
MindWalk Holdings is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.